OKYO Pharma Limited (LON:OKYO)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at GBX 9.13 ($0.12), but opened at GBX 9.63 ($0.13). OKYO Pharma shares last traded at GBX 9.43 ($0.12), with a volume of 269,795 shares changing hands.
The stock has a market cap of £63.42 million and a PE ratio of -91.80. The firm’s 50-day moving average is GBX 9.37 and its 200 day moving average is GBX 10.11. The company has a debt-to-equity ratio of 0.41, a quick ratio of 17.82 and a current ratio of 17.94.
OKYO Pharma Company Profile (LON:OKYO)
OKYO Pharma Limited operates as a life sciences and biopharmaceutical company in the United Kingdom. Its pre-clinical development program includes Chemerin for the treatment of ocular inflammation, dry eye disease, and ocular neuropathic pain; and BAM8, a non-opioid analgesic. OKYO Pharma Limited is headquartered in London, the United Kingdom.
Featured Article: How to start trading in the forex market?
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.